Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Accentia Biopharmaceuticals, Inc -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (7)	7/22/2008 7:51:37 AM
From: kenhott	Respond to of 8

Here is the Biovest CC from yesterday. vcall.com Looks like they picked up the trial from the NCI. So someone else screwed up the design of the trial before them. But all these years and they were only able to enroll 234. All kinds of what ifs. Blame it on mgt at the end. The company is desperate, doing desperate stuff, and half full of fibs. But even with all this crap, they still might might might have a chance but only if dummies look pass the crap and into the value of the drug. But we know people are smart, way too smart for this. One thing is certain, it will be entertaining. Get the popcorn ready.